We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App





SARSTEDT Demonstrates Pre-Analytic Innovations for Improving Specimen Quality, Reducing TAT and Automating Labs

By LabMedica International staff writers
Posted on 26 Jul 2023
Print article
Image: The Tempus600 lineup enables one-touch sample transport from point of collection to the laboratory (Photo courtesy of SARSTEDT)
Image: The Tempus600 lineup enables one-touch sample transport from point of collection to the laboratory (Photo courtesy of SARSTEDT)

SARSTEDT (Nümbrecht, Germany), a leader in pre-analytic innovation, is demonstrating its solutions for improving specimen quality, reducing turnaround time, and automating labs of all sizes with customizable modular systems at AACC 2023. The company’s pre-analytical experts are leading short in-booth workflow walkthroughs at the SARSTEDT booth.

SARSTEDT is also hosting an industry workshop where Dr. Mark Kellogg, Associate Director of Chemistry at Boston Children’s Hospital (Boston, MA, USA) will be presenting on maximizing pediatric laboratory efficiency through automation and improved quality small-volume S-Monovette® primary tubes. Dr. Kellogg will be discussing improving sample rejection rates by reducing hemolysis, clotting, and improper labeling, as well as integrating the S-Monovette® into a total laboratory automation process.

Visitors to the SARSTEDT booth can also check out the lighted tubes traveling overhead. On display is the SARSTEDT Tempus600®, a dedicated transportation system for sending specimen tubes quickly and reliably to the laboratory without batching or packing them into carriers. Sample tubes arrive within seconds at a laboratory receiving station for immediate processing. Samples arrive continuously as sent, reducing peaks for a faster and more predictable workflow. SARSTEDT will be demonstrating how the Tempus600® and IVD systems such as the Roche cobas® connection modules work together to shorten the time between tests being ordered and results being ready. Visitors can watch as blood collection tubes leave the SARSTEDT booth and arrive at the Roche booth in seconds.

Related Links:
SARSTEDT 
Boston Children’s Hospital 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.